Table 3. Costs and disability adjusted life year (DALY) results over one year per primary episode treated in the base case analysis and probabilistic sensitivity analysis (PSA).

All costs are in 2014 United States Dollars.

	Mean costs		Mean DALYs
	Base case	PSA (95% CrI*)	Base case	PSA (95% CrI*)
Males
Chloroquine strategy	38.0	37.8 (24.6 to 55.5)	0.034	0.034 (0.009 to 0.137)
Primaquine strategy	45.3	45.8 (31.6 to 62.6)	0.019	0.019 (0.007 to 0.050)
Screening strategy	38.2	38.6 (25.2 to 55.3)	0.007	0.008 (0.003 to 0.018)
Females
Chloroquine strategy	38.0	38.3 (24.0 to 54.4)	0.034	0.034 (0.009 to 0.155)
Primaquine strategy	40.5	41.2 (28.3 to 59.0)	0.015	0.015 (0.006 to 0.040)
Screening strategy	38.3	39.1 (25.6 to 57.3)	0.011	0.011 (0.004 to 0.030)

* Credible interval.